Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02190968 · ClinicalTrials.gov registry record · NA
Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance
A NA study, sponsored by University of Toronto.
- Completed
- Registry status
- NA
- Development phase
- 460
- Enrollment target
NCT02190968 is a NA study that has completed, run by University of Toronto. The registered enrollment target is 460 participants.
The verdict
NCT02190968, a NA study, has completed, sponsored by University of Toronto.
- COMPLETED
- Registry status
- NA
- Development phase
- 460 participants
- Enrollment target
Study Summary
Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targets RDS by teaching specific emotion regulation and depression self-management skills that are entirely compatible with antidepressant treatment. The investigators now propose a controlled study to determine whether MMB is more effective than usual care at reducing RDS and other key outcomes. If successful, MMB's online delivery format would provide high fidelity and low-cost empirically supported management of residual symptoms, leading to more robust remission, improved functioning and sustained recovery from MDD over time.
Interventions
- BEHAVIORAL Usual Depression Care
- BEHAVIORAL Mindful Mood Balance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02190968
The ClinicalTrials.gov registry entry for NCT02190968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Toronto, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Depression Care is the first listed.
NCT02190968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02190968 about?
NCT02190968 is a clinical study titled "Reducing Residual Depressive Symptoms With Web-based Mindful Mood Balance". Many patients report residual depressive symptoms despite seemingly successful treatment. With the investigators' previous funding, we developed - Mindful Mood Balance - an online treatment that targets RDS by teaching specific emotion regulation and depression self-management skills that are entire...
What is the current status of trial NCT02190968?
This trial is currently completed. It is a NA study. The enrollment target is 460 participants. The study started on 2015-03. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02190968?
The interventions under investigation include: Usual Depression Care (BEHAVIORAL), Mindful Mood Balance (BEHAVIORAL).
Who is sponsoring clinical trial NCT02190968?
This trial is sponsored by University of Toronto, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.